Deadly Bundibugyo Virus Spreads Across Central Africa as WHO Declares Global Emergency

Unprecedented Outbreak Challenges Medical Response

A devastating Ebola outbreak caused by the rare Bundibugyo virus is rapidly spreading across Central Africa, with 550 confirmed cases, including 101 confirmed related deaths reported as of early June 2026. Unlike previous Ebola epidemics, this outbreak presents unique challenges that have forced global health officials to confront an enemy for which they have no proven weapons.

The crisis began in May when WHO received an alert regarding an unknown illness with high mortality in Mongbwalu Health Zone, Ituri Province, Democratic Republic of the Congo, including reports of four health workers who died within four days . What makes this outbreak particularly alarming is that there are currently two approved vaccines against Ebola disease, but neither is approved for use in cases of infection with the Bundibugyo virus .

The World Health Organization declared this outbreak a public health emergency of international concern (PHEIC) on May 17, marking the 17th Ebola disease outbreak DRC has experienced since the first case was discovered in 1976, and the third to specifically involve the Bundibugyo virus .

Cross-Border Spread Raises International Concerns

The virus has already crossed international borders, with Uganda reporting a total of 19 confirmed cases, including two deaths . Most concerning is that two confirmed cases were reported in Kampala, Uganda on 15 and 16 May following travel from the Democratic Republic of the Congo, with both confirmed cases admitted to intensive care units in Kampala .

The outbreak is occurring in areas affected by insecurity, population displacement, mining-related population movement, and frequent cross-border travel, all of which may increase the risk of further transmission . Healthcare workers are particularly vulnerable, with patients presenting with symptoms including fever, generalized body pain, weakness, vomiting, and in some cases bleeding, with several patients reportedly deteriorating rapidly and dying .

The geographic spread continues to expand, with cases now confirmed across Ituri province with 518 confirmed cases from 17 health zones, North Kivu with 29 confirmed cases from seven health zones and South Kivu with three cases from one health zone .

Medical Arsenal Proves Inadequate

The Bundibugyo strain presents unprecedented challenges for medical professionals worldwide. There is currently no approved treatment for Ebola disease caused by Bundibugyo virus , forcing doctors to rely primarily on supportive care. The two monoclonal antibody treatments that proved effective against the more common Zaire strain of Ebola showed monoclonal antibody treatments improved the chances of survival for people with the Ebola virus, but not the Bundibugyo virus .

However, there is some hope on the horizon. The Coalition for Epidemic Preparedness Innovations announced funding in order to fast-track three vaccine candidates targeting Bundibugyo ebolavirus , though these remain in early development stages. Previous outbreaks of this strain have shown case fatality rates ranging from 30% to 50% , though current data suggests slightly lower mortality rates with intensive supportive care.

Global Response Mobilizes Against Time

International aid is flowing rapidly into the affected region. The UK announced up to £20 million to support communities affected by the Ebola outbreak, the US State Department announced $112 million of bilateral assistance, and the European Union pledged €15 million to support Ebola response and preparedness efforts .

The CDC has mobilized extensive resources, with CDC issuing a Level 3 Travel Health Notice for DRC and a Level 2 Travel Health Notice for Uganda, while providing outreach and preparedness information for the public, clinical guidance for health care providers, and guidance for state, tribal, local, and territorial partners . Despite these efforts, the risk of spread to the United States is considered low at this time .

The race against this outbreak will likely determine not just the fate of Central Africa, but also test the global community's ability to respond to emerging infectious diseases in an interconnected world. With no specific treatments available and vaccines still in development, the coming weeks will prove critical in containing what could become one of the most challenging Ebola outbreaks in recent history.